Pro Medicus (PME.AX) Stock Price

Pro Medicus Price

🇦🇺ASX·CLOSED
172.93AUD
Market closed
Today +/-
Today %

Pro Medicus (PME.AX) Stock | ISIN AU000000PME8 | WKN 591723. The current Pro Medicus stock price is 172.93 AUD (2026). Revenue is 277 M AUD. Net income is 176 M AUD. The P/E ratio is 102.83. Market capitalization is 18.1 B AUD. Pro Medicus operates in the Health sector.

Revenue has compounded at 16.6% per year over the past 19 years to 220.54 M AUD. Earnings per share have grown at 16.5% per year over the last 19 years. Pro Medicus's net margin stands at 52.2%, up from 45.3% several years earlier. Pro Medicus currently offers a dividend yield of about 0.45%. The payout ratio is around 74% of earnings. The dividend has grown at 20.9% per year over the past 19 years.

Pro Medicus stock price

Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Pro Medicus over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Pro Medicus stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Pro Medicus's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Pro Medicus Stock Price History
DatePro Medicus Price
Access this data via the Eulerpool API
Get Free API Key

Pro Medicus Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
11.86 M AUD
8.49 M AUD
6.12 M AUD
Jan 1, 2007
13.2 M AUD
9.73 M AUD
7.05 M AUD
Jan 1, 2008
15.41 M AUD
11.33 M AUD
7.93 M AUD
Jan 1, 2009
15.62 M AUD
6.5 M AUD
5.68 M AUD
Jan 1, 2010
19.46 M AUD
5.3 M AUD
3.92 M AUD
Jan 1, 2011
14.07 M AUD
1.4 M AUD
500,000 AUD
Jan 1, 2012
11.38 M AUD
210,000 AUD
1.79 M AUD
Jan 1, 2013
11.37 M AUD
-990,000 AUD
5.13 M AUD
Jan 1, 2014
14.45 M AUD
2.54 M AUD
1.51 M AUD
Jan 1, 2015
17.58 M AUD
3.46 M AUD
3.22 M AUD
Jan 1, 2016
27.58 M AUD
9.59 M AUD
6.37 M AUD
Jan 1, 2017
31.62 M AUD
14.19 M AUD
9.32 M AUD
Jan 1, 2018
33.93 M AUD
14.84 M AUD
9.97 M AUD
Jan 1, 2019
50.35 M AUD
25.71 M AUD
19.13 M AUD
Jan 1, 2020
56.99 M AUD
30.24 M AUD
23.08 M AUD

Pro Medicus Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 23, 2026, 4:16 PM
 
REVENUE (M AUD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M AUD)
NET INCOME (M AUD)
NET INCOME GROWTH (%)
DIV. (AUD)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
202420252026e2027e2028e2029e2030e2031e
166220277356439475490533
30.7132.5325.9128.5223.318.23.168.78
10010079.4261.850.1146.3244.941.28
166220220220220220220220
82115176199251278244263
36.6740.2453.0413.0726.1310.76-12.237.79
0.570.790.461.411.78---
32.5638.6-41.77206.5226.24–––
104.65104.66104.66104.66104.66104.66104.66104.66
––––––––
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Pro Medicus generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Pro Medicus retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Pro Medicus's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Pro Medicus has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Pro Medicus's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Pro Medicus stock margins

The Pro Medicus margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pro Medicus. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pro Medicus.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
98.23 %
71.59 %
51.6 %
Jan 1, 2007
98.79 %
73.71 %
53.41 %
Jan 1, 2008
99.68 %
73.52 %
51.46 %
Jan 1, 2009
96.03 %
41.61 %
36.36 %
Jan 1, 2010
90.85 %
27.24 %
20.14 %
Jan 1, 2011
96.73 %
9.95 %
3.55 %
Jan 1, 2012
95.17 %
1.85 %
15.73 %
Jan 1, 2013
95.87 %
-8.71 %
45.12 %
Jan 1, 2014
98.06 %
17.58 %
10.45 %
Jan 1, 2015
98.73 %
19.7 %
18.3 %
Jan 1, 2016
97.76 %
34.76 %
23.09 %
Jan 1, 2017
98.35 %
44.87 %
29.48 %
Jan 1, 2018
99.35 %
43.73 %
29.37 %
Jan 1, 2019
97.2 %
51.07 %
37.98 %
Jan 1, 2020
99.38 %
53.06 %
40.49 %

Pro Medicus Stock Revenue, EBIT, Earnings per Share

The Pro Medicus earnings per share therefore indicates how much revenue Pro Medicus has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2006
0.12 AUD
0.08 AUD
0.06 AUD
Jan 1, 2007
0.13 AUD
0.1 AUD
0.07 AUD
Jan 1, 2008
0.15 AUD
0.11 AUD
0.08 AUD
Jan 1, 2009
0.16 AUD
0.06 AUD
0.06 AUD
Jan 1, 2010
0.19 AUD
0.05 AUD
0.04 AUD
Jan 1, 2011
0.14 AUD
0.01 AUD
0 AUD
Jan 1, 2012
0.11 AUD
0 AUD
0.02 AUD
Jan 1, 2013
0.11 AUD
-0.01 AUD
0.05 AUD
Jan 1, 2014
0.14 AUD
0.03 AUD
0.02 AUD
Jan 1, 2015
0.17 AUD
0.03 AUD
0.03 AUD
Jan 1, 2016
0.27 AUD
0.09 AUD
0.06 AUD
Jan 1, 2017
0.3 AUD
0.14 AUD
0.09 AUD
Jan 1, 2018
0.33 AUD
0.14 AUD
0.1 AUD
Jan 1, 2019
0.48 AUD
0.25 AUD
0.18 AUD
Jan 1, 2020
0.55 AUD
0.29 AUD
0.22 AUD

Pro Medicus business model & stock analysis

Pro Medicus Ltd. is an Australian company specializing in the development and distribution of medical imaging software solutions. The company was founded in 1983 and is headquartered in Melbourne.

Pro Medicus SWOT Analysis

Strengths

Pro Medicus Ltd has several key strengths:

  • Strong brand reputation and recognition in the healthcare industry.
  • Advanced and innovative technology solutions.
  • Robust financial performance and steady revenue growth.
  • Well-established partnerships and customer relationships.

Weaknesses

Pro Medicus Ltd also faces certain weaknesses:

  • Limited geographical presence and reliance on specific market segments.
  • Dependency on key clients for a significant portion of revenue.
  • Relatively small size compared to some major competitors.

Opportunities

Pro Medicus Ltd should consider the following opportunities:

  • Expanding into new markets and geographic regions.
  • Diversifying product offerings to cater to a wider range of healthcare professionals.
  • Capitalizing on the growing demand for telemedicine and remote healthcare solutions.
  • Forming strategic partnerships to enhance market reach and penetration.

Threats

Pro Medicus Ltd should be aware of potential threats:

  • Intense competition from larger and more established players in the industry.
  • Technological advancements and rapid changes in the healthcare landscape.
  • Regulatory and compliance challenges in different markets.
  • Economic fluctuations and uncertainties affecting healthcare budgets.

Pro Medicus Eulerpool Fair Value

Pro Medicus historical P/E ratio, EBIT multiple, and P/S ratio

Pro Medicus annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Pro Medicus shares outstanding

The number of shares was Pro Medicus in 2025 — This indicates how many shares 104.662 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2006
100.73 M base_Shares
Jan 1, 2007
100.38 M base_Shares
Jan 1, 2008
100.43 M base_Shares
Jan 1, 2009
100.28 M base_Shares
Jan 1, 2010
100.28 M base_Shares
Jan 1, 2011
100.28 M base_Shares
Jan 1, 2012
100.26 M base_Shares
Jan 1, 2013
100.26 M base_Shares
Jan 1, 2014
100.26 M base_Shares
Jan 1, 2015
102.48 M base_Shares
Jan 1, 2016
101.38 M base_Shares
Jan 1, 2017
104.12 M base_Shares
Jan 1, 2018
104.29 M base_Shares
Jan 1, 2019
104.43 M base_Shares
Jan 1, 2020
104.46 M base_Shares

Pro Medicus Dividend History

26 years of dividend payments · 10 consecutive increases

YearAnnual DividendYoY ChangePayments
20260.46AUDYTD—1×
Feb 26, 20260.46AUD↑ 6.7%1/1
20250.79AUD↑ 37.5%2×
Feb 27, 20250.36AUD↑ 13.6%1/2
Sep 3, 20250.43AUD↑ 20.0%2/2
20240.57AUD↑ 33.3%2×
20230.43AUD↑ 36.4%2×
20220.31AUD↑ 46.7%2×
20210.21AUD↑ 25.0%2×
20200.17AUD↑ 14.3%2×
20190.15AUD↑ 78.6%3×
20180.08AUD↑ 65.6%2×
20170.05AUD↑ 69.0%2×

Pro Medicus dividend history and estimates

In 2025, Pro Medicus paid a dividend amounting to 0.79 AUD. Dividend means that Pro Medicus distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Invalid Date
0 AUD
0.02 AUD
0.01 AUD
Invalid Date
0 AUD
0.02 AUD
0.02 AUD
Invalid Date
0.09 AUD
-0.01 AUD
0.01 AUD
Jan 1, 2009
0.05 AUD
0 AUD
0 AUD
Invalid Date
0.03 AUD
0.03 AUD
0 AUD
Invalid Date
0.03 AUD
0.03 AUD
0 AUD
Invalid Date
0.02 AUD
-0.01 AUD
0 AUD
Jan 1, 2013
0.03 AUD
0 AUD
0 AUD
Jan 1, 2014
0.03 AUD
0 AUD
0 AUD
Jan 1, 2015
0.02 AUD
0 AUD
0 AUD
Jan 1, 2016
0.03 AUD
0 AUD
0 AUD
Jan 1, 2017
0.05 AUD
0 AUD
0 AUD
Jan 1, 2018
0.08 AUD
0 AUD
0 AUD
Jan 1, 2019
0.15 AUD
0 AUD
0.04 AUD
Jan 1, 2020
0.17 AUD
0 AUD
0 AUD

Pro Medicus dividend payout ratio

In 2025, Pro Medicus had a payout ratio of 74.15%. The payout ratio indicates the percentage of the company's profits that Pro Medicus distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2006
35.71 %
Jan 1, 2007
30.61 %
Jan 1, 2008
107.14 %
Jan 1, 2009
83.33 %
Jan 1, 2010
71.43 %
Jan 1, 2011
74.73 %
Jan 1, 2012
214.29 %
Jan 1, 2013
57.14 %
Jan 1, 2014
142.86 %
Jan 1, 2015
63.69 %
Jan 1, 2016
47.77 %
Jan 1, 2017
56.66 %
Jan 1, 2018
87.86 %
Jan 1, 2019
81.92 %
Jan 1, 2020
77.6 %
Price targets and forecasts for Pro Medicus are not yet available.

Pro Medicus Earnings Estimates

Pro Medicus Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
2/13/20240.37AUD74.25 MAUD2024 Q2
8/16/20230.3AUD65.82 MAUD2023 Q4
2/14/20230.26AUD59.87 MAUD2023 Q2
8/18/20220.21AUD50.4 MAUD2022 Q4
2/16/20220.19AUD43.5 MAUD2022 Q2
8/18/20210.18AUD40.44 MAUD2021 Q4
2/17/20210.15AUD38.05 MAUD2021 Q2
8/20/20200.11AUD31.28 MAUD2020 Q4
2/13/20200.11AUD28.65 MAUD2020 Q2
8/22/20190.08AUD23.95 MAUD2019 Q4

EESG©

Eulerpool ESG Scorecard© for the Pro Medicus stock

34/100
45
Environment
36
Social
23
Governance
E

Environment

20
Scope 1 - Direct Emissions1.9
Scope 2 - Indirect emissions from purchased energy118.9
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions120.9
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees26.7
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Pro Medicus shareholder structure

% Name
23.11467%
Hupert (Sam Aaron)
Hupert (Sam Aaron)
23.07297%
Hall (Anthony Barry)
Hall (Anthony Barry)
1.71442%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.08086%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
0.9298%
Vanguard Investments Australia Ltd.
Vanguard Investments Australia Ltd.
0.91935%
Norges Bank Investment Management (NBIM)
Norges Bank Investment Management (NBIM)
0.60164%
Kempen (Peter Terence)
Kempen (Peter Terence)
0.60065%
BetaShares Capital Ltd.
BetaShares Capital Ltd.
0.52625%
Franklin Advisers, Inc.
Franklin Advisers, Inc.
0.4785%
Brown Capital Management, LLC
Brown Capital Management, LLC
...

Pro Medicus Executives and Management Board

MW

Mr. Malte Westerhoff

General Manager Europe and Global Chief Technology Officer

Compensation1.59 M AUD
SL

Mr. Sean Lambright

Global Head of Sales - Visage Imaging Inc

Compensation1.21 M AUD
SH

Dr. Sam Hupert

Chief Executive Officer, Managing Director, Executive Director · since 2010

Compensation965,221 AUD
CH

Mr. Clayton Hatch

Chief Financial Officer

Compensation500,773 AUD
DT

Mr. Danny Tauber

General Manager - Australia · since 2011

Compensation423,573 AUD

Pro Medicus Supply Chain

Frequently asked questions about Pro Medicus

The business model of Pro Medicus Ltd revolves around providing advanced healthcare imaging software solutions. The company specializes in developing and delivering a comprehensive range of radiology solutions that enhance workflow efficiency and improve patient care. Pro Medicus offers cutting-edge products like Visage AI, Visage 7, and Visage RIS, which allow healthcare professionals to efficiently manage and analyze medical images. By combining innovative technology with a customer-centric approach, Pro Medicus helps healthcare providers worldwide optimize their imaging operations and deliver accurate diagnoses. With its focus on developing state-of-the-art software solutions, Pro Medicus positions itself as a leader in the medical imaging industry.

All fundamentals and in-depth analysis of Pro Medicus

Our stock analysis for Pro Medicus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pro Medicus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Pro Medicus Stock
Pro Medicus Revenue→
Pro Medicus Stock
Pro Medicus Net Income→
Pro Medicus Stock
Pro Medicus P/E→
Pro Medicus Stock
Pro Medicus P/S→
Pro Medicus Stock
Pro Medicus EBIT→
Pro Medicus Stock
Pro Medicus Dividend→
Pro Medicus Stock
Pro Medicus Directors Dealings→
Pro Medicus Stock
Pro Medicus Stocks→
Pro Medicus Stock
Pro Medicus Market capitalization→
Pro Medicus Stock
Pro Medicus Debt→
Pro Medicus Stock
Pro Medicus Liabilities→
Pro Medicus Stock
Pro Medicus Equity→
Pro Medicus Stock
Pro Medicus AAQS→
Pro Medicus Stock
Pro Medicus Employees→
Pro Medicus Stock
Pro Medicus ROE→
Pro Medicus Stock
Pro Medicus ROA→
Pro Medicus Stock
Pro Medicus ROCE→